Close Menu

NEW YORK (GenomeWeb) – Australian molecular diagnostics firm Genetic Technologies said on Wednesday that it has entered into a securities purchase agreement with certain institutional investors in the US.

Under the agreement, the investors will purchase approximately 1.5 million American Depository Shares (ADS), each representing 150 of the company's ordinary shares, at a price of $.80 per ADS.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

US National Institutes of Health Director Francis Collins says he will avoid male-only speaker panels.

Two patients fell ill, and one subsequently died, following a fecal microbiome transplant that harbored multi-drug-resistant bacteria, according to the New York Times.

Technology Review reports that eGenesis is testing whether organs from genetically modified pigs can be transplanted into monkeys.

In Science this week: almond reference genome, and more.